Restless leg syndrome: diagnosis and treatment
Glas. Srpska akademija nauka i umetnosti. Odeljenje medicinskih nauka 2009(50): 73-81
2009
ISSN/ISBN: 0371-4039 PMID: 20666116 Document Number: 629037
Although it may have significant adverse impact on quality of life of patients who suffer from it, restless legs syndrome remains a largely overlooked disorder. In addition to sensorimotor discomfort, it may also be a significant cause of excessive daytime sleepiness or fatigue. The dopamine agonists ropinirole and pramipexole are currently considered to be the agents of choice for the treatment of RLS. A number of non-pharmacological maneuvers may also be beneficial and complement pharmacological treatments.